These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7117899)

  • 1. Disposition of oral metronidazole in hepatic cirrhosis and in hepatosplenic schistosomiasis.
    Daneshmend TK; Homeida M; Kaye CM; Elamin AA; Roberts CJ
    Gut; 1982 Oct; 23(10):807-13. PubMed ID: 7117899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug metabolism in hepatosplenic schistosomiasis in the Sudan: a study with antipyrine.
    Homeida M; Salih SY; Branch RA
    Gut; 1978 Sep; 19(9):808-11. PubMed ID: 710970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxamniquine pharmacokinetics in hepatosplenic schistosomiasis in the Sudan.
    Daneshmend TK; Homeida MA
    J Antimicrob Chemother; 1987 Jan; 19(1):87-93. PubMed ID: 3104279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol disposition in patients with hepatosplenic schistosomiasis.
    Homeida MM; Ali HM; Arbab BM; Harron DW
    Br J Clin Pharmacol; 1987 Sep; 24(3):393-6. PubMed ID: 3663453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefoperazone in normal subjects and patients with hepatosplenic schistosomiasis.
    Boscia JA; Korzeniowski OM; Kobasa WD; Rocha H; Levison ME; Kaye D
    J Antimicrob Chemother; 1983 Oct; 12(4):407-10. PubMed ID: 6643335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theophylline metabolism in patients with hepatosplenic mansoniasis and cirrhosis.
    Cukier A; Strauss E; Terra Filho M; Santos SR; Vargas FS
    J Hepatol; 1992 May; 15(1-2):35-9. PubMed ID: 1506654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intestinal absorption in the hepatosplenic form of schistosomiasis mansoni].
    Mott CB; Neves DP; Bettarello A
    Rev Hosp Clin Fac Med Sao Paulo; 1971 Apr; 26(2):55-60. PubMed ID: 5089431
    [No Abstract]   [Full Text] [Related]  

  • 8. Altered drug metabolism in hepatosplenic schistosomiasis.
    Brant PC; Prata A
    Rev Inst Med Trop Sao Paulo; 1979; 21(5):254-9. PubMed ID: 549210
    [No Abstract]   [Full Text] [Related]  

  • 9. Output of 14CO2 in breath after oral administration of (14C-methyl) aminopyrine in hepatitis, cirrhosis and hepatic bilharziasis: its relationship to aminopyrine pharmacokinetics.
    Noordhoek J; Dees J; Savenije-Chapel EM; Wilson JH
    Eur J Clin Pharmacol; 1978 May; 13(3):223-9. PubMed ID: 668778
    [No Abstract]   [Full Text] [Related]  

  • 10. [Plasma clearance of bromsulphalein in patients with the hepatosplenic form of schistosomiasis mansoni].
    Sáez-Alquézar A; Magnanelli AC; Ohtsuki N; Strauss E; da Silva AT; Raia S; da Silva LC
    Rev Hosp Clin Fac Med Sao Paulo; 1979 Apr; 34(2):48-53. PubMed ID: 39325
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmacokinetics of antipyrine in patients with graded severity of schistosomiasis.
    el-Raghy I; Back DJ; Osman F; Nafeh MA; Orme ML
    Br J Clin Pharmacol; 1985 Oct; 20(4):313-6. PubMed ID: 4074599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of hemolysates test of ascitic fluid in late stage of schistosomiasis and cirrhosis of liver (author's transl)].
    Huang MX
    Zhonghua Nei Ke Za Zhi; 1980 May; 19(3):192-5. PubMed ID: 7227053
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of metronidazole given to horses by intravenous and oral routes.
    Sweeney RW; Sweeney CR; Soma LR; Woodward CB; Charlton CA
    Am J Vet Res; 1986 Aug; 47(8):1726-9. PubMed ID: 3752681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid metabolism in bilharzial cirrhosis.
    Ghanem MH; Fahmy MH; Aboul-Kheir F; Mikhail MN; Guirgis FK
    Atherosclerosis; 1970; 12(1):55-61. PubMed ID: 5482261
    [No Abstract]   [Full Text] [Related]  

  • 15. Differentiating cirrhosis and chronic hepatosplenic schistosomiasis using MRI.
    Bezerra AS; D'Ippolito G; Caldana RP; Leopoldino DD; Batista GR; Borges DR; Lopes Filho Gde J; Ahmed M
    AJR Am J Roentgenol; 2008 Mar; 190(3):W201-7. PubMed ID: 18287413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatosplenic schistosomiasis: a great neglected disease of the liver.
    Warren KS
    Gut; 1978 Jun; 19(6):572-7. PubMed ID: 355069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum trypsin in hepatosplenic schistosomiasis in the Sudan.
    Fedail SS; elMasri SH; Harvey RF
    Trop Med Parasitol; 1990 Dec; 41(4):441-2. PubMed ID: 2075392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exocrine pancreatic function in hepatosplenic schistosomiasis in the Sudan.
    Fedail SS; Baher YM; Aboud OI
    Digestion; 1985; 32(2):132-5. PubMed ID: 4043563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of dose and route of administration on disposition of metronidazole and its major metabolites.
    Loft S; Døssing M; Poulsen HE; Sonne J; Olesen KL; Simonsen K; Andreasen PB
    Eur J Clin Pharmacol; 1986; 30(4):467-73. PubMed ID: 3743624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Hepatic Arterial Blood Flow Measured by Hepatic Perfusion Index in Hepatosplenic Schistosomiasis: New Concepts for an Old Disease.
    de Carvalho BT; Coutinho Domingues AL; de Almeida Lopes EP; Brandão SC
    Dig Dis Sci; 2016 Jul; 61(7):2118-26. PubMed ID: 26921079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.